Biocept's cnside cerebrospinal fluid assay identifies actionable her2 mutations in patients with breast cancer that has metastasized to the brain

San diego--(business wire)--sabcs spotlight presentation shows that biocept's cnside csf assay identifies actionable her2 mutations in metastatic breast cancer.

BIOC Ratings Summary

BIOC Quant Ranking